Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma

doi:10.5306/wjco.v15.i1.45

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3012)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1815

Figures (1-8)

172

Tables (1-2)

159

Sum=2206

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

107

Download

324

Sum=431

Publishing Process of This Article

Item

Count

Browse

Download

225

Sum=317

Jan 24, 2024 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Jan 24, 2024; 15(1): 45-61
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.45

Full Size Figure Download Figure

Figure 6 The prognostic value of HSPA4 in the different subgroups. A and B: The prognostic value of HSPA4 in overall survival and disease specific survival of lung adenocarcinoma patients; C–H: High expression of HSPA4 was associated with worse overall survival in different subgroups.

Citation: Wu X, Yang SY, Zhang YH, Fang JZ, Wang S, Xu ZW, Zhang XJ. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma. World J Clin Oncol 2024; 15(1): 45-61
URL: https://www.wjgnet.com/2218-4333/full/v15/i1/45.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i1.45